The approval of the first malaria treatment for newborns and young infants could lead to imminent widespread use in Africa, ...

Researchers at Karolinska Institutet have identified over 250 proteins that are strongly affected by malaria, which could help predict the severity of the disease and thus enable faster treatment for ...

The WHO’s 2025 guidance outlines strategies for preventing malaria resurgence in countries that have achieved elimination, ...

Researchers at Karolinska Institutet have identified over 250 proteins that are strongly affected by malaria, which could ...

Coartem® (artemether-lumefantrine) Baby becomes first malaria treatment approved for newborn babies and young infants Rapid approvals in eight African countries now expected under a special global ...

Switzerland’s medical products authority has granted the first approval for a malaria medicine designed for small infants.

Malaria caused 597,000 deaths worldwide in 2023, with children under 5 accounting for 76 percent of all malaria deaths in the ...

Novartis said on Tuesday it had received approval in Switzerland for Coartem Baby, which it said was the first drug to treat ...

The new drug, developed by Novartis and MMV, isn't a malaria vaccine, but can help treat babies with the disease.

The pharmaceutical industry is criticizing the Trump administration’s plan for carrying out a critical round of Medicare drug ...

The medicine, called Coartem Baby (also known as Riamet Baby), was approved by Switzerland’s health agency, Swissmedic.

Discover the history of quinine, a cure for malaria hidden in the jungles of South America, saving countless lives.